Aether Biomachines is a legitimate, high-potential Series B biotechnology company with significant funding (~$64M) and a verifiable valuation (~$245M). The project scores highly on technical innovation and real-world utility due to its application of AI and robotics to enzyme engineering. However, the submission itself was of extremely poor quality, containing demonstrable falsehoods regarding audience reach ('everyone', 'most people have used my product') and lacking descriptive detail. The score reflects the strong fundamentals of the underlying business, heavily penalized for the inaccurate and lazy submission data.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline